National Oesophago-Gastric Cancer Audit 2019

Reports | Published: 13 Dec 2019

The National Oesophago-Gastric Cancer Audit (NOGCA) was established to evaluate the quality of care received by patients with oesophago-gastric (OG) cancer in England and Wales.

It collects prospective data on adult patients diagnosed in England and Wales with invasive epithelial cancer of the oesophagus, gastro-oesophageal junction (GOJ) or stomach, and patients diagnosed with high grade dysplasia (HGD) of the oesophagus. This report describes the care received by patients diagnosed between April 2016 and March 2018 and their outcomes.

All 134 NHS acute trusts in England and the 6 local health boards in Wales participated in the 2016-18 audit period.

19.12.2019: Version 2 – We have re-issued the 2019 NOGCA Annual report (published on Friday 13 December) to correct some figures in the Executive Summary that relate to the care of patients with high grade dysplasia (pages 3 and 4) and some figures in the infographics (pages 7 and 8).  We regret the original report contained these errors and apologise for any inconvenience this may have caused.  The report conclusions and recommendations are unchanged and the figures in the main body of the report were correct.

You can download the report here.

Stay-up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.

Don’t miss out. Sign up to be notified when this resource is updated and to receive updates about other related quality improvement resources, events and news from HQIP. Or you can  .

By continuing you agree to receive emails with updates and other information from HQIP and you are confirming you are over the age of 13.

Please read our privacy policy to understand how HQIP uses the information you provide, your use of HQIP’s website and your interaction with the marketing emails to improve the relevance of the communications we send you. You can unsubscribe at any time.

I have read and agree with the contents of the privacy policy.

National Oesophago-Gastric Cancer Audit 2019